Better Dividend: Merck & Co., Inc. (MRK) or Pfizer Inc. (PFE)?
Neither company has a stellar track record when it comes to dividends.
Posts Tagged ‘Bristol Myers Squibb Co. (BMY)’
Better Buy: Pfizer Inc. (PFE) or Zoetis Inc (ZTS)?
Pfizer Inc. (NYSE:PFE) recently spun off animal health firm Zoetis Inc (NYSE:ZTS) in the form of an IPO.
Merck & Co., Inc. (MRK)’s Dynamic Duo
Merck & Co., Inc. (NYSE:MRK) lost blockbuster asthma drug Singulair off the patent cliff last year, and the sales plunge quickly followed.
Will Pfizer Inc. (PFE) Help You Retire Rich?
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
This Just In: Upgrades and Downgrades – Dendreon Corporation (DNDN) and More
At The Motley Fool, we poke plenty of fun at Wall Street analysts and their endless cycle of upgrades, downgrades, and "initiating coverage at neutral." Today, we'll show you ...
Reckitt Benckiser Group Plc (RB) Reveals 300 Million Pound Latin America Tie-In
LONDON -- Shares in Reckitt Benckiser Group Plc (LON:RB) lifted this morning following the group's positive fourth-quarter and full-year earnings release, with management declaring...
3 Events Biotech Investors Need to Watch in 2013: Vical Incorporated (VICL) and More
It's make-or-break time in 2013. That's the situation for several biotech companies with critical phase 3 trials under way.
Can Johnson & Johnson (JNJ) Hold Its Ground in the Multiple Myeloma Market?
Johnson & Johnson (NYSE:JNJ) may offer well-known personal care products such as Listerine and Neutrogena, but it also boasts an impressive portfolio of market leading therapeutic...
We Love You, Just Not Enough to Buy You (Yet): Regeneron Pharmaceuticals Inc (REGN), Sanofi SA (SNY)
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) said Monday that it got a notice from its partner Sanofi SA (NYSE:SNY) saying that the pharma intends to buy additional shares of the...
Will Johnson & Johnson (JNJ) Win Approval for Its Diabetes Drug?
In addition to its well-known personal-care products such as Listerine and Neutrogena, Johnson & Johnson (NYSE:JNJ) boasts an impressive portfolio of market-leading therapeutic...
Has Gilead Sciences, Inc. (GILD) Become the Perfect Stock?
One thing's for sure: You'll never discover truly great investments unless you actively look for them.
Celgene Corporation (CELG): Still Revving Up With Revlimid
What a roll Celgene Corporation (NASDAQ:CELG) has been on lately. The company has experienced success after success in recent months.
5 Big Winners and Losers From Earnings Season: Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Eli Lilly & Co. (LLY)
Earnings season is a wrap for many of the brightest stars of the health care sector: Big pharma's big disappointments and successes are in the books, and investors are looking...
What Will Type 2 Diabetes Treatments Look Like in 5 Years? Merck & Co., Inc. (MRK), AstraZeneca plc (AZN)
Times are changing in the biotech sector.
Sanofi SA (SNY)’s New Diabetes Play Moves Forward
Sanofi SA (ADR) (NYSE:SNY) starts the week with a new European Union approval for the type 2 diabetes injectable Lyxumia.
Two Peas in a Pharma Pod: Pfizer Inc (PFE), Bristol Myers Squibb Co. (BMY)
Pfizer's 2012 revenue was down 10%; Bristol-Myers Squibb's was off by 17%. Both are down because of expirations of megablockbusters they used to own.
Why Sanofi SA (NYSE:SNY) is Set for a Great 2013
Last year was a pretty good one for stockholders in Sanofi SA (NYSE:SNY), and the indications are that this year could be the same.
One of the Easiest Ways to Build a Retirement Nest Egg I’ve Ever Seen
Some people built their fortunes by reinvesting dividends. My mother was one of them. For example, she parlayed a $2,500 investment in Bristol Myers Squibb Co.
3 High-Yield Pharma Stocks With Major Catalysts
Income investors can find attractive high-yields in the pharmaceutical sector right now. Many major drug makers, including familiar names like Merck & Co., Inc.
